News

News Center

Nine national ministries and commissions jointly issued a document: prioritizing the development of stem cell, immune cell, and gene therapy products.

2022-03-08

Recently, nine departments—the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Commerce, the National Health Commission, the Ministry of Emergency Management, the National Healthcare Security Administration, the National Medical Products Administration, and the State Administration of Traditional Chinese Medicine—jointly issued the "14th Five-Year Plan for the Pharmaceutical Industry."

The "Pharmaceutical Industry Development Plan for the 14th Five-Year Period," specifically "Column 1: Industrialization Project for Innovative Pharmaceutical Products," outlines the following priorities for biopharmaceuticals: In the antibody drug sector, the focus will be on advancing novel antibody therapies targeting diseases such as cancer, immune-related disorders, viral infections, and hyperlipidemia, as well as next-generation immune checkpoint modulators, multifunctional antibodies, G-protein coupled receptor (GPCR) antibodies, and antibody-drug conjugates (ADCs). Additionally, combination therapies involving antibodies alongside other therapeutic agents will be encouraged. In the vaccine field, key areas of development include innovative COVID-19 vaccines, herpes vaccines, multivalent human papillomavirus (HPV) vaccines, and polyvalent combination vaccines. In the recombinant protein drug segment, the emphasis will be on pioneering new-targeted therapeutics, along with upgrading and enhancing existing drugs through the adoption of long-acting technologies and innovative delivery methods. In other areas, Focus on developing immune cell therapies such as chimeric antigen receptor T-cell (CAR-T) and chimeric antigen receptor NK-cell (CAR-NK) therapies targeting novel targets and indications, as well as stem cell therapies, gene therapy products, and specific immunoglobulins.

The "Bio-pharmaceutical Industrialization Technology Breakthrough Project" outlined in "The 14th Five-Year Plan for Pharmaceutical Industry Development" highlights the following focus areas for biopharmaceutical technologies: Key efforts will be directed toward developing ultra-large-scale (≥10,000-liter/vessel) cell culture technologies, as well as next-generation products such as bifunctional antibodies, antibody-drug conjugates, peptide-drug conjugates, novel recombinant protein vaccines, and nucleic acid vaccines. Industrial-scale manufacturing technologies for innovative biopharmaceuticals such as cell therapies and gene therapies, novel drug delivery methods and advanced delivery systems, and next-generation vaccine adjuvants.

Reprint Notice: This article is reprinted from the official website of the Ministry of Industry and Information Technology. If there is any infringement, please contact us for removal.

A member of the National Committee of the Chinese People's Political Consultative Conference has proposed moderately opening up diversified investments in areas such as stem cells and gene technology, aiming to strengthen and expand the bioeconomy.

National Committee of the Chinese People's Political Consultative Conference (CPPCC) 13th National Conference, Session 5: Commends Stem Cell Research for Pioneering in "Uncharted Territory"

Here is the title—h1 placeholder text

Online Message

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business license